Biblio
Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy. EMBO Mol Med. 2019:e11115.
Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes. J Am Heart Assoc. 2014;3(6).
Gene Therapy for Inherited Arrhythmias. Cardiovasc Res. 2020.
. Gene therapy strategies in the treatment of hypertrophic cardiomyopathy. Pflugers Arch. 2018.
. Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy. Stem Cell Res. 2021;55:102489.
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: From molecular mechanisms to therapeutic targets. Eur J Heart Fail. 2021.
Translational investigation of electrophysiology in hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2021.